CPC Clinical Research
CPC Clinical Research is a nonprofit academic research organization providing full-service clinical trial design, oversight, and management to pharmaceutical and biotech sponsors across Phase I-IV studies. Leveraging its University of Colorado affiliation and the ATLAS/Pedi-ATLAS collaborative networks, it delivers scientifically-led, academically-credible trial services in cardiovascular and antithrombotic therapy.
- Company typePrivate
- Founded1989
- HeadquartersAurora, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What CPC Clinical Research does
CPC Clinical Research, founded in 1989, is a nonprofit 501(c)(3) academic research organization (ARO) headquartered in Aurora, Colorado, that delivers full-service clinical trial design, oversight, and management to pharmaceutical and biotech sponsors. Also operating as the Colorado Prevention Center, CPC provides a unified service suite spanning scientific oversight, biostatistics, data management, global project management, medical affairs, site monitoring, and the proprietary EQuIP (Endpoint Quality Intervention Program) for endpoint adjudication quality assurance. The organization manages Phase I to IV trials across national and international geographies, having supported over 150 clinical studies cumulatively.
The company's business model is professional services: it engages pharmaceutical and biotech sponsors directly through business development and field sales, delivering enterprise-scale clinical research contracts on a quote-based pricing model. CPC's principal differentiator is its unique affiliation agreement with the University of Colorado, which grants access to faculty and Key Opinion Leaders, and the integrated ATLAS and Pedi-ATLAS multinational collaborative networks for adult and pediatric antithrombotic trials respectively. Revenue mechanics are not publicly disclosed, consistent with the nonprofit structure. Recent strategic emphasis has been on cardiovascular, vascular, and antithrombotic trial capabilities, supported by senior talent hires and academic output channels including publications and conference presence at ACC, AHA, ESC, and ISTH.
CPC Clinical Research firmographics
Firmographics- Name
- CPC Clinical Research
- Legal name
- CPC Clinical Research
- Website
- https://cpcclinicalresearch.org
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- CPC Clinical Research is a nonprofit academic research organization providing full-service clinical trial design, oversight, and management to pharmaceutical and biotech sponsors across Phase I-IV studies. Leveraging its University of Colorado affiliation and the ATLAS/Pedi-ATLAS collaborative networks, it delivers scientifically-led, academically-credible trial services in cardiovascular and antithrombotic therapy.
- Ownership category
- akta.pro rank
CPC Clinical Research industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Investigator & Site Training / GCP Support (HLAGACAF), Clinical Research & Trial Central Laboratories (HLAFAMAL)
Keywords
Where CPC Clinical Research is headquartered
LocationHeadquarters
- HQ city
- Aurora
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
CPC Clinical Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Research Services: Full service clinical trial design, oversight, and management provided to pharmaceutical and biotech sponsors. Services include scientific oversight, biostatistics, data management, global project management, medical affairs, site monitoring, and endpoint quality services.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
CPC Clinical Research product offering
Product offeringCore offering
CPC Clinical Research is a nonprofit 501(c)(3) academic research organization that delivers full-service clinical trial design, oversight, and management for pharmaceutical and biotech sponsors. The offering covers Phase I–IV trials and bundles scientific oversight, biostatistics, data management, global project management, medical affairs, site monitoring, and the proprietary EQuIP endpoint quality intervention program. Services are grounded in a unique University of Colorado faculty affiliation and KOL access, with leadership experienced on FDA advisory committees.
Product overview
CPC Clinical Research operates as a nonprofit 501(c)(3) academic research organization offering a unified suite of clinical trial management services. The core service portfolio comprises Scientific Oversight, Full Service Clinical Research, Biostatistics, Data Management, Global Project Management, Medical Affairs, Site Monitoring, and the proprietary EQuIP (Endpoint Quality Intervention Program). The organization has provided services to over 150 clinical studies across Phase I to IV trials for more than 30 years. Additionally, CPC supports academic development through the William R. Hiatt Vascular Medicine Fellowship and maintains strategic partnerships with the ATLAS Group (adult-focused antithrombotic trials) and Pedi-ATLAS Group (pediatric-focused antithrombotic trials), which serve as collaborative academic thought leadership modules complementing the core clinical research services.
Differentiator
Problem solved
Functional benefit
Brands
- ATLAS Group: Adult-focused, multinational, multidisciplinary, multi-institutional collaborative group of hematology, cardiology, and antithrombotics experts
- Pedi-ATLAS Group
Products and services
- Full Service Clinical Research Full-service clinical trial design, oversight, and management delivered to pharmaceutical and biotech sponsors across Phase I to IV, with rapid access to Key Opinion Leaders in multiple therapeutic areas and FDA advisory committee experience.
- EQuIP (Endpoint Quality Intervention Program) Proprietary endpoint quality assurance program that standardizes and improves the accuracy of clinical trial endpoint adjudication and assessment, with supporting Core Lab services for endpoint adjudication, imaging, and biomarkers.
Companies that use CPC Clinical Research
Customer profileSegments2 records
Ideal customer profiles1 record
CPC Clinical Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
CPC Clinical Research partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- ATLAS Group (Antithrombotic Trials Leadership and Steering)coreATLAS is an adult-focused, multinational, multidisciplinary, multi-institutional collaborative group of hematology, cardiology, and antithrombotics experts. CPC partners with ATLAS to provide ARO-CRO model services including management of trial oversight committees, endpoint adjudication, imaging and biomarker core labs, and independent statistical analyses.
- University of ColoradocoreCPC has a unique affiliation agreement with the University of Colorado that allows CPC to utilize the faculty, providing a deeper level of therapeutic expertise. This affiliation is fundamental to CPC's identity as an academic research organization.
- Pedi-ATLAS GroupcorePedi-ATLAS is a multinational, multidisciplinary, multi-institutional group of pediatric antithrombotic therapy trialists. Similar to the ATLAS partnership, CPC provides ARO services including trial oversight committee management, endpoint quality training and monitoring, and independent validation of statistical analyses.
- Denver HealthminorAffiliation logo displayed on CPC website indicating collaborative relationship
- National Jewish HealthminorAffiliation logo displayed on CPC website indicating collaborative relationship
- Johns Hopkins All Children's HospitalcoreMultiple faculty members from Johns Hopkins All Children's Hospital are affiliated with CPC through ATLAS and Pedi-ATLAS groups, including Dr. Neil Goldenberg (Chief Research Officer) and Dr. Ernest Amankwah (Director of Epidemiology and Biostatistics)
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
CPC Clinical Research competitors and assessment
Company assessmentDirect peers
- Medpace Holdings: Mid-size, science-focused full-service CRO with strong therapeutic expertise in cardiovascular and metabolic trials, mirroring CPC's combination of scientific credibility and operational delivery.
- Worldwide Clinical Trials: Mid-size global CRO with therapeutic specialization in cardiovascular, metabolic, and central nervous system trials, comparable in scale and therapeutic focus to CPC's offerings.
- Celerion: Specialty early-phase CRO with scientific expertise in clinical pharmacology and cardiovascular safety, similar in size and specialty-service positioning to CPC's core lab and scientific oversight offerings.
- Montreal Health Innovations Coordinating Center (MHICC): Academic coordinating center affiliated with the Montreal Heart Institute, providing clinical trial operations, biostatistics, and endpoint adjudication primarily in cardiovascular research.
- Baim Institute for Clinical Research: Academic cardiovascular and vascular clinical research organization offering full-service trial design, oversight, and endpoint adjudication — nearly identical operating model and therapeutic focus to CPC.
- Duke Clinical Research Institute (DCRI): One of the largest academic research organizations in the world, affiliated with Duke University and providing Phase I–IV trial design, biostatistics, and clinical operations across multiple therapeutic areas including cardiovascular.
Broad incumbents
- Syneos Health: Large global biopharmaceutical solutions organization spanning clinical development and commercialization, competing with CPC across multiple therapeutic categories at significantly greater scale.
- ICON plc: One of the world's largest CROs offering full-service Phase I–IV clinical trial services across all major therapeutic areas; competes with CPC on large cardiovascular and metabolic programs while serving a much broader portfolio.
- IQVIA: Largest global CRO with technology-driven clinical development services, deep data assets, and broad therapeutic coverage; sets the competitive benchmark against which niche AROs like CPC must differentiate.
- Parexel International: Large global CRO with strong cardiovascular and metabolic therapeutic expertise, providing full-service clinical development and post-approval services to pharma and biotech sponsors worldwide.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
CPC Clinical Research social profiles
Digital presenceCPC Clinical Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
CPC Clinical Research leadership team
Management profileNumber of profiles
Profiles2 records
CPC Clinical Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CPC Clinical Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CPC Clinical Research
What does CPC Clinical Research do?
CPC Clinical Research is a nonprofit 501(c)(3) academic research organization that delivers full-service clinical trial design, oversight, and management for pharmaceutical and biotech sponsors. The offering covers Phase I–IV trials and bundles scientific oversight, biostatistics, data management, global project management, medical affairs, site monitoring, and the proprietary EQuIP endpoint quality intervention program. Services are grounded in a unique University of Colorado faculty affiliation and KOL access, with leadership experienced on FDA advisory committees.
Is CPC Clinical Research a public or private company?
CPC Clinical Research is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was CPC Clinical Research founded?
CPC Clinical Research was founded in 1989. It employs 101 to 250 people.
Where is CPC Clinical Research based?
CPC Clinical Research is headquartered in Aurora, United States, in the North America region.
How does CPC Clinical Research make money?
One revenue line is on record: clinical Research Services.
Who are CPC Clinical Research's main competitors?
Direct peers on record are Medpace Holdings, Worldwide Clinical Trials, Celerion, Montreal Health Innovations Coordinating Center (MHICC), Baim Institute for Clinical Research and Duke Clinical Research Institute (DCRI). Broad incumbents are Syneos Health, ICON plc, IQVIA and Parexel International.
Does CPC Clinical Research have an API?
No public API is recorded for CPC Clinical Research.
What industry is CPC Clinical Research in?
CPC Clinical Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGACAF, Investigator & Site Training / GCP Support. Its NAICS code is 5417 and its SIC code is 8731.